Skip to main content
. 2020 Sep 15;8(1):e001261. doi: 10.1136/bmjdrc-2020-001261

Table 3.

Baseline characteristics

Weight-based
(n=283)
Glucose-based
(n=292)
Demographic characteristics
Sex (M, %) 168 (59.4) 168 (57.5)
Age (years) 58.9 (8.8) 59.7 (9.2)
Diabetes duration (years) 6.3 (6.7) 7.0 (7.5)
Weight (kg) 64.4 (11.4) 65.5 (11.8)
BMI (kg/m2) 24.4 (3.9) 24.7 (3.9)
Clinical characteristics
HbA1c (%) 10.9 (2.4) 11.1 (2.5)
C-peptide (μg/L) 2.2 (2.1) 2.0 (1.1)
Admission BG (mmol/L) 17.9 (5.3) 18.6 (5.4)
Admission diagnosis (n, %)
 Uncontrolled hyperglycemia 181 (64.0) 179 (61.3)
 DK/DKA 45 (15.9) 52 (17.8)
 Pneumonia 18 (6.4) 7 (2.4)
 Urine tract infection 24 (8.5) 28 (9.6)
 Diabetic foot 9 (3.2) 17 (5.8)
 Other infections 6 (2.1) 9 (3.1)
Previous diabetes treatment (n, %)
 None 106 (37.5) 108 (37.0)
 OHA or GLP-1RA 95 (33.6) 97 (33.2)
  One type 25 (8.8) 24 (8.2)
  Two types 33 (11.7) 31 (10.6)
  Three or over three types 37 (13.1) 42 (14.4)
 Insulin alone 23 (8.1) 28 (9.6)
 Both OHA and insulin 38 (13.4) 37 (12.7)

Values are n (%) or mean (SD) unless otherwise stated. Other infection includes upper respiratory infection, skin ulcer and shingles.

BG, blood glucose; BMI, body mass index; DK, diabetic ketosis; DKA, diabetic ketoacidosis; GLP-1RA, glucagon-like peptide-1 receptor agonist; HbA1c, hemoglobin A1c; OHA, oral hypoglycemic agent.